8086 — Nipro Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Annual income statement for Nipro, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	442,516	455,559	494,789	545,199	586,785
Cost of Revenue
Gross Profit	134,212	138,841	149,270	163,450	171,320
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	453,377	438,518	475,714	530,539	570,736
Operating Profit	-10,861	17,041	19,075	14,660	16,049
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-10,158	17,519	23,243	16,777	19,219
Provision for Income Taxes
Net Income After Taxes	-11,591	15,038	15,066	5,934	12,170
Minority Interest
Net Income Before Extraordinary Items
Net Income	-12,280	14,210	13,455	4,575	11,110
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-12,281	14,209	13,455	4,574	11,109
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	92.2	159	110	40.1	89.5
Dividends per Share